Alphina Therapeutics is based in New Haven. It has raised $40M in total funding. Latest round: Series A.
Alphina Therapeutics is based in New Haven. Alphina Therapeutics has raised $40M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in September 2021. The round record for Alphina Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include Canaan Partners, Osage University Partners, Connecticut Innovations, HighCape Partners, Alexandria Venture Investments. 5 distinct backers are named across the disclosed rounds.
Round data for Alphina Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in New Haven and backer lists below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026